scholarly journals HBsAg, Anti-HBs, Anti-HCV and Anti-HIV Seroprevalence of the Patients Applied to Artvin State Hospital

2013 ◽  
Vol 19 (1) ◽  
pp. 41-44 ◽  
Author(s):  
Ayşe İNCİ ◽  
Demirhan GÜVEN ◽  
Murat OKAY
Keyword(s):  
State Hospital ◽  
Hiv Seroprevalence ◽  
Anti Hiv

RETROSPECTIVE STUDY OF PREVALENCE OF HIV IN BLOOD DONORS AT A.D.GORWALA BLOOD BANK

2021 ◽  
pp. 42-43
Author(s):  
Neha Patel ◽  
Sanjay Chaudhari ◽  
Sonal Chitroda
Keyword(s):  
Retrospective Study ◽  
Blood Transfusion ◽  
Hiv Infection ◽  
Blood Donors ◽  
Blood Donation ◽  
Cumulative Effect ◽  
Blood Bank ◽  
Hiv Seroprevalence ◽  
Safe Blood ◽  
Anti Hiv

Background: India has the second highest HIV population in the world with about 2.5-3.0 million cases. Blood transfusion saves millions of lives worldwide each year but Blood transfusion is an important mode of transmission of infections to recipients and at the same time it is also associated with large number of complications including transfusion-transmissible infections (TTIs). Aims & objective: to study the prevalence of HIVin blood donors of A.D.Gorwala Blood bank From January 2005 To December 2010. Methods: A retrospective study was conducted among blood donors through the years 2005-2010. Sera from blood donors were tested for the detection of Anti HIV by using third generation ELISA tests, strictly following the instruction of manufacturers. The donor information was collected through the donor registers from A.D. Gorwala Blood Bank. Result: From the total of 28,371 screened blood samples collected, the prevalence of HIV in blood donors in the blood bank was 0.23% in the ve consecutive years but the trend of HIV infection has decreased from 2005(0.31%) to 2010 (0.04%). The age groups18-30 has the highest prevalence and the age group 51-60 was the lowest prevalence of HIV infection. The Prevalence of HIV among male (0.18%) was higher than in female donors (0.05%). The trend of HIVinfection was decreasing for both male and female blood donors. Conclusion: The analysis of HIV seroprevalence among blood donors through the year 2005- 2010 showed a signicantly decreasing trend, probably due to the cumulative effect of increasing awareness of HIVand improved screening system for safe blood donation.

scholarly journals HBV, HCV and HIV Seroprevalence in Syrian Refugee Patient Population Undergoing Preoperative Anaesthetic Assessment: A 10-Year Survey in a Tertiary Teaching Hospital

2021 ◽  
Author(s):  
Mehmet Çömez ◽  
Tayibe Bal ◽  
Mehmet Çabalak
Keyword(s):  
Patient Group ◽  
Major Surgery ◽  
Hiv Seroprevalence ◽  
Seropositivity Rate ◽  
Turkish Patient ◽  
Syrian Refugee ◽  
Tertiary Teaching ◽  
Hbsag Seropositivity ◽  
Turkish Patients ◽  
Anti Hiv

Objective: Migration can lead to a change in the demographic dynamics of host populations in terms of communicable diseases in destination countries. This is a potential public health challenge for health authorities. HBV and HCV infections can lead to the development of chronic liver diseases, cirrhosis and hepatocellular carcinoma, and HIV infection can lead to the development of serious opportunistic diseases. The aim of this study is to evaluate the seroprevalence of HBV, HCV and HIV in Syrian refugees and Turkish patients who were evaluated preoperatively in our hospital. Materials and methods: HBsAg, Anti-HBs, Anti-HBc, Anti-HCV and Anti-HIV results of Syrian refugee and Turkish patients who applied to surgical clinics between 2011-2021 were retrospectively reviewed. Results: The study is comprised of 54446 patients: Turkish patient group (n=20569) and Syrian refugee patient group (n=33877). The Syrian refugee patients had a significantly higher HBsAg seropositivity rate and a significantly lower anti-HBs seropositivity rate than the Turkish patients (p=0.002 and p<0.001, respectively). The anti-HCV and anti-HIV seropositivity rates were similar. The annual preoperative prevalance of HBsAg seropositivity in the Syrian refugee patients tended to significantly decrease gradually from year 2011 to year 2021 (p<0.001 for ≤30 and p=0.001 for >30 years old). Conclusion: As a result, although HBV seroprevalence gradually decreases and HCV and HIV seroprevalence is low; screening, information and treatment programs should be given due importance because of the serious disease potential and preventable conditions with precautions. In addition, preoperative screening of refugee patients coming for major surgery may be important for the safety of healthcare professionals.

Sign in / Sign up

Export Citation Format

Share Document